Fibromuscular dysplasia (FMD) is a significant cause of renal artery stenosis, especially in young females. A rare association between FMD and ␣ 1 -antitrypsin (␣ 1 -AT) deficiency has been reported. We compared the ␣ 1 -AT phenotype distribution in 83 patients with renal arterial FMD with those published for Australian populations. ␣ 1 -AT phenotyping was performed by isoelectric focusing between pH 4.2 and pH 4.9 on polyacrylamide gels with PiM1M2, PiFM (non-deficiency alleles), PiMS and PiMZ (deficiency alleles) markers. Following phenotyping, ␣ 1 -AT genotyping was performed in 10 patients to confirm the presence of S and/or Z alleles. The phenotype distribution and allele frequencies were similar to those reported for normal subjects from two Australian populations (72 (86.7%) PiMM phenotype, one (1.2%) PiFM, seven (8.4%) PiMS, two (2.4%) PiMZ and
Introduction
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease 1 most commonly affecting the renal, internal carotid and external iliac arteries. FMD is the most common cause of renovascular hypertension in patients presenting under 40 years of age, and affects women three times more frequently than men. 1 Although rare, arterial dissection is a complication of FMD, and is recognised as a cause of stroke in the young. 1 The most abundant proteinase inhibitor in human plasma is ␣ 1 -antitrypsin (␣ 1 -AT) and is thought to be important in protection against proteases, particularly neutrophil elastase. 2 The highly polymorphic ␣ 1 -AT gene identified at C14q32 has more than 70 allelic variants, most of which do not result in decreased plasma ␣ 1 -AT levels. 2 The alleles most commonly associated with ␣ 1 -AT deficiency are S and Z. 2 Homozygotes for the Z allele have ␣ 1 -AT levels which are only 12-18% of normal, and are at increased risk of lung and liver disease. 2 The PiMZ and PiMS phenotypes have mean ␣ 1 -AT levels approximately 65% and 85% of normal, respectively. While an association between FMD and ␣ 1 -AT deficiency has been reported, [3] [4] [5] [6] [7] [8] [9] we are aware of only nine patients in all. Other rare associations between ␣ 1 -AT deficiency and other cardiovascular pathology such as intracranial aneurysms, 10, 11 cerebral artery dissection, 8, 10 mesenteric artery aneurysm rupture, 12 and iliac artery dissection 13 have also been reported.
In the current study we tested the hypothesis that patients with renal arterial FMD have a higher prevalence of ␣ 1 -AT deficiency than the general community. We determined ␣ 1 -AT phenotypes in 83 patients with renal arterial FMD, and compared these to published phenotype distributions in Australian populations.
14,15

Materials and methods
One hundred and seven patients referred to a hypertension unit between 1970 and 1997 were diagnosed with FMD of the renal arteries. Twenty-four patients were excluded from the present study, comprising eight who were deceased, 11 who were lost to follow-up, and five from whom an appropriate blood sample could not readily be obtained. Causes of death in the eight deceased patients were carcinoma (four patients), alcohol-related liver disease (one patient), postoperative haemorrhage (one patient), myocardial infarction (one patient) and unknown (one patient).
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The remaining 83 patients were interviewed by one of the authors (AB). Duration of hypertension was determined as the number of years between the first diagnosis of sustained hypertension and the diagnosis of FMD.
The diagnosis of FMD was confirmed by angiographic (80 patients) and/or pathologic (21 patients) examination. All angiograms were reviewed by three of the authors (AB, CH, ND). Each FMD-affected renal artery was classified as unifocal (focal or tubular) or multifocal. A focal lesion was defined as a solitary stenosis of less than 1 cm in length, and a tubular lesion as a smooth, concentric stenosis of greater than 1 cm in length. A multifocal lesion was defined as two or more adjacent stenoses (significantly more in the majority) giving the characteristic 'beaded' appearance. Lesions were classified as unilateral (right or left) or bilateral. 'Unilateral renal atrophy' was defined as a difference in bipolar length of greater than 2 cm between the two kidneys on IVP or renal angiography.
␣ 1 -AT phenotyping was performed by isoelectric focusing between pH 4.2 and pH 4.9 on polyacrylamide gels using PiM1M2, PiMS, PiMZ and PiFM markers. Following phenotyping, ␣ 1 -AT genotyping was performed in 10 patients, using the method of Anderson et al 16 to confirm the presence of S and/or Z alleles.
Statistical analysis was performed using Statistica software (Release 5.0, StatSoft, Inc. Tulsa, USA). Parametric data were expressed as mean (± standard deviation), and non-parametric as median (range). The t-test for independent samples was used for parametric data, the Mann-Whitney U test for nonparametric data, the Fisher exact test for differences between proportions, and the Chi square test for differences between observed and expected phenotype frequencies. A two-sided probability value of less than 0.05 was considered statistically significant.
Results
Sixty patients (54 female) had multifocal disease and 23 (17 female) had unifocal disease. Seventytwo (86.7%) of the patients were PiMM phenotype, one (1.2%) PiFM, seven (8.4%) PiMS, two (2.4%) PiMZ and one (1.2%) PiSZ (Table 1) . That is, 10 (12%) of the patients had deficiency phenotypes Comparison of the 10 deficiency phenotype patients with the 73 non-deficiency phenotype patients revealed no significant differences in gender distribution, age at diagnosis of FMD, duration of hypertension, type of FMD lesion, number with bilateral FMD, nor number with unilateral renal atrophy.
However, two patients with deficiency phenotypes are of interest. A 50-year-old male with PiMS deficiency phenotype suffered a spontaneous dissection of the right internal carotid artery and was found to have bilateral renal arterial FMD. The single patient with PiSZ phenotype in this series was one of two sisters with FMD, and presented aged 44 with bilateral renal artery and iliac artery multifocal FMD, severe right renal artery stenosis and unilateral renal atrophy. She had no clinical evidence of lung or liver pathology. Her sister with FMD and PiMM phenotype presented at age 57 with bilateral mild renal artery FMD, no renal atrophy and iliac artery multifocal FMD.
Discussion
In a retrospective review of 6696 autopsies performed at the Mayo Clinic, 3 25 patients had FMD, six had ␣ 1 -AT deficiency and only two (with PiZZ phenotype) had both. In one of these, the FMD affected the renal arteries, and, in the other, the iliac arteries. Both patients with FMD and ␣ 1 -AT deficiency died of disseminated fungal infection with mycotic aneurysms during post-transplant immunosuppressive therapy.
A search of the literature revealed only seven additional patients with FMD and ␣ 1 -AT deficiency. [4] [5] [6] [7] [8] [9] Only one of these was said to have renal arterial FMD. 9 A 15-year-old girl with ␣ 1 -AT deficiency (PiZZ phenotype) died of a ruptured splenic artery aneurysm associated with medial fibroplasia following orthotopic liver transplantation. 4 A 16-year-old girl with mild ␣ 1 -AT deficiency (PiMP phenotype) had a giant intracranial aneurysm of the middle cerebral artery associated with intimal FMD. 5 An 11-year-old boy with ␣ 1 -AT deficiency (PiSZ phenotype) had a left middle cerebral artery occlusion and a 'string-of-beads' appearance in the supraclinoid portion of the left internal carotid artery. 6 Two females with ␣ 1 -AT deficiency (both PiMZ phenotype) had bilateral internal carotid stenosis caused by FMD. 7 A 59-year-old female with ␣ 1 -AT deficiency (phenotype PiMS) had a dissecting aneurysm of the right vertebral artery, a saccular aneurysm of the posterior communicating artery, and FMD of the left vertebral artery. 8 A 47-year-old female with ␣ 1 -AT deficiency (PiZZ phenotype) and mild pulmonary symptoms presented with rupture of the right renal artery 25 years after removal of a small, non-functioning left kidney. 9 The present study of 83 patients with renal arterial FMD found a similar distribution of ␣ 1 -AT deficiency phenotypes to that in the general population, suggesting that an ␣ 1 -AT deficiency phenotype is not a common aetiological factor in the development of renal arterial FMD. The literature would support this, since such an association has been rarely reported. However, in two of 10 patients with ␣ 1 -AT deficiency phenotype in the present series, it is possible that the ␣ 1 -AT deficiency contributed to the severity of the disease. Thus, in two sisters with FMD, the sister with the deficiency (PiSZ) phenotype presented at a younger age and with a significantly more severe degree of disease than her PiMM phenotype sibling. A second patient with a deficiency phenotype (PiMS) and internal carotid artery dissection and bilateral renal artery FMD was of male gender, where the incidence of FMD is lower, and internal carotid artery dissection is a rare manifestation of FMD in either sex. 1 Elastase is capable of degrading a variety of substrates, 2 including elastin, collagen types III and IV, fibronectin and the basement membrane, [19] [20] [21] and ␣ 1 -AT, which inactivates a wide range of proteases, provides approximately 90% of the antielastase activity in plasma. 2 Excessive elastase activity is the accepted basis of lung damage in ␣ 1 -AT deficiency states in humans: destruction of elastic fibres by human neutrophil elastase produces emphysema in experimental animal models. 22 It has been suggested that ␣ 1 -AT may also have an important role in protecting blood vessels. 2, 23 When temporal arteries from 24 patients with intracranial aneurysms were compared with those from 10 patients with benign, non-vascular intracranial pathology, the group with aneurysms had higher plasma elastase levels and immunohistological evidence of greater degradation of arterial elastin. 24 In contrast with a 2-4% prevalence in the general population, 11% of 47 patients with abdominal aortic aneurysm had an ␣ 1 -AT deficiency phenotype (PiMZ). 25 A deficiency of ␣ 1 -AT could therefore result in arterial wall degradation through inadequate protection against proteolytic activity. 2, 7, [23] [24] [25] An effect such as this might predispose to increased severity of multifocal FMD and also to arterial dissection in FMD.
While the prevalence of renal arterial FMD in autopsy studies has been only approximately 1%, 3, 26 renal artery FMD has been reported in 3.5% of potential living renal transplant donors, 27 who would have been carefully studied, bringing into question the true prevalence of FMD. Similarly, while severe ␣ 1 -AT deficiency (PiZZ phenotype) is considered rare, partial deficiency (PiMS and PiMZ phenotypes) has been described in 10% to 15% of the Australian population 14, 15 and was present in 12% of patients in the present study.
Since milder forms of ␣ 1 -AT deficiency are not uncommon, and the prevalence of FMD is uncertain, chance associations between the two might be expected. Since the frequency of ␣ 1 -AT deficiency was no higher in the patients with FMD in the present study than that reported for the general population, it is very unlikely that ␣ 1 -AT deficiency is a common aetiological factor in the development of FMD. However, in two individual patients in the present series and nine culled from the literature,
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there is a possibility that the chance association of FMD and ␣ 1 -AT deficiency led to more severe manifestations of FMD.
